Labshake search
Citations for R&D Systems :
401 - 450 of 958 citations for 7 BROMO 2 CHLOROQUINOLINE 3 CARBONITRILE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: Primary antibodies used for immunofluorescent staining were: active caspase-3 (Rabbit, R&D Systems, AF835); laminin alpha3 chain (Mouse ...
-
bioRxiv - Bioengineering 2023Quote: ... medium was changed to 3 mL CDM with 10 ng/mL VEGF (R&D Systems), SB431542 (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 20 ng/mL IL-3 and 20 ng/mL SCF (R&D Systems), 2% FBS ...
-
bioRxiv - Cell Biology 2019Quote: ... secreted IL-2 samples were diluted 1:10 and subsequently analyzed using Mouse IL-2 Quantikine ELISA Kit (R&D Systems Inc, Minneapolis, MN), as per manufacturer’s specifications.
-
bioRxiv - Cancer Biology 2022Quote: PBMC (2×106 per well) were stimulated in 24-well plates with peptide (individual/pool) plus recombinant IL-2 (R&D Systems Europe Ltd.) at a final concentration of 5μg/mL and 20IU/mL ...
-
bioRxiv - Microbiology 2022Quote: ... The resulting supernatant was used to measure levels of inflammation marker Lipocalin-2 using the Duoset murine Lcn-2 ELISA kit (R&D Systems, Minneapolis, MN).
-
bioRxiv - Evolutionary Biology 2023Quote: Lipocalin-2 concentration in the supernatants was measured using the commercial kit Mouse Lipocalin-2/NGAL DuoSet ELISA (R&D Systems, Minneapolis, MN, USA) for mouse Lipocalin-2 (DY1857) ...
-
bioRxiv - Immunology 2022Quote: ... 2 ng/mL recombinant human TGF-β1 (R&D Systems), and 333 ng/mL anti-IgD dextran conjugates (Fina Biosolutions) ...
-
bioRxiv - Pathology 2019Quote: ... FGF-2 (20ng/mL, R&D Systems 233-FB-025) and EGF (20ng/mL ...
-
bioRxiv - Immunology 2021Quote: ... 100 IU/ml recombinant human IL-2 (R&D Systems), and 50 μM beta-mercaptoethanol (Fisher) ...
-
bioRxiv - Bioengineering 2021Quote: ... Human/Mouse/Rat/Hamster ACE-2 (R&D systems, AF933), Human TRA-1-85/CD147 (R&D systems ...
-
bioRxiv - Microbiology 2019Quote: ... or FGF-2 protein levels using ELISA (R&D systems). The LDH release was calculated as described previously (83).
-
bioRxiv - Cancer Biology 2022Quote: ... and 50 IU/mL of IL-2 (R&D Systems)] for 7 days prior to use in cell killing assays ...
-
bioRxiv - Biochemistry 2022Quote: ... 2 µg of recombinant Mac-1 integrin (R&D systems) was incubated with reduced PDI or enzymatically inactive PDI at 10 µM for 30 min at 25°C ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 ng/ul GDNF (R&D Systems #212-GD)) ...
-
bioRxiv - Genomics 2019Quote: ... and 2 ng/mL recombinant human GDNF (R&D Systems).
-
bioRxiv - Evolutionary Biology 2020Quote: ... 2 U/ml EPO (R&D Systems, 287-TC-500), 40 ng/ml IGF-1 (Miltenyi ...
-
bioRxiv - Immunology 2021Quote: ... or biotinylated goat-anti-mouse Dectin-2 (R&D Systems) followed by APC-conjugated streptavidin antibodies (Biolegend) ...
-
bioRxiv - Cell Biology 2021Quote: ... and 2 ng/mL recombinant human GDNF (R&D Systems).
-
bioRxiv - Microbiology 2023Quote: ... The mouse lipocalin-2/NGAL detection kit (R&D Systems) ELISA kit and HRP-Streptavidin (Biolegend ...
-
bioRxiv - Microbiology 2023Quote: ... SARS-CoV-2 Spike S2 Subunit Antibody (R&D systems), IRDye® 800CW Goat anti-Human IgG (H + L) ...
-
bioRxiv - Microbiology 2023Quote: ... Primary anti-human ACE-2 antibody (#AF933, R&D systems) or isotype-matched antibody (#AB-108-C ...
-
bioRxiv - Immunology 2023Quote: ... Human IL-2 was from R&D Systems (Minneapolis, MN). Vero E6 cells were purchased from ATCC ...
-
bioRxiv - Bioengineering 2023Quote: ... 2 mg/mL Cultrex® Collagen (R&D Systems, 344702001) solution in neuron media ...
-
bioRxiv - Immunology 2023Quote: ... fibroblast growth factor-2 (FGF-2;20ng/mL;R&D systems) and Platelet-derived growth factor (PDGF-AA;20ng/mL;R&D systems ...
-
bioRxiv - Immunology 2023Quote: ... Then biotinylated Spike proteins (WA-2, 2P, R&D systems) were subsequently captured to a level of 3-500RU by the neutravidin ...
-
bioRxiv - Immunology 2024Quote: ... 30 IU/ml recombinant human IL-2 (R&D Systems) and 50 µM β-mercaptoethanol (Fisher) ...
-
bioRxiv - Biochemistry 2022Quote: ... or 1:1000 anti-Human/Mouse/Rat PRL-3 Antibody (R&D Systems, MAB3219, Lot. WXH0419091). Following three washes with 0.1% TBST ...
-
bioRxiv - Genomics 2019Quote: ... and 10 ng/ml recombinant human transforming growth factor beta 3 (rhTGF-b3) (R&D Systems). Pellets were formed at the end of passage 6 ...
-
bioRxiv - Neuroscience 2021Quote: ... coated plates in the expansion medium (N2B27) supplemented with 3 µM CHIR (R&D System, 4423), 0.5 µM PMA (Cayman Chemical ...
-
bioRxiv - Cancer Biology 2019Quote: ... TIM-3-Alexa Fluor 488 (344823) and TIGIT-APC (741182) antibodies (all from R&D Systems); CD4-APC-H7 (L200) ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... The human active recombinant Caspase-3 (#707-C3) was purchased from R&D Systems (Minneapolis, USA). Purified Human active Cathepsin-B (#BML-SE198) ...
-
bioRxiv - Microbiology 2019Quote: ... CC3 staining was performed using rabbit polyclonal anti-active Caspase-3 antibody (AF835, R&D systems) and peroxidase-labelled anti-rabbit EnVision™ secondary antibody (Dako ...
-
bioRxiv - Immunology 2020Quote: ... serum was collected 3 hr after injection and cytokines were quantified by ELISA (R&D systems) following the manufacturer’s protocol.
-
bioRxiv - Microbiology 2022Quote: ... and the Human IL-29/IL-28B (IFNλ1/3) DuoSet ELISA (DY1589, R&D Systems, USA) kit according to the manufacturer’s protocol.
-
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccinebioRxiv - Immunology 2022Quote: ... plates were incubated for 2 h at RT with 500 ng/mL (25 ng/well) recombinant biotinylated human ACE-2 (R&D Systems, Cat# BT933-020) diluted in PBSTBA ...
-
bioRxiv - Immunology 2023Quote: ... and were cultured with 50U/ml hIL-2 (Th0) or 100U/ml hIL-2 and 5ng/ml murine TGFβ (R&D Systems, 7666-MB/CF) for 4-5 days.
-
bioRxiv - Developmental Biology 2021Quote: ... 2 ng/ml SCF (R&D Systems, cat. 455-MC-010), 500 ng/ml EGF (R&D Systems ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 ng/ml GDNF (R&D Systems 212-GD-050). Cells conditioned the media for 3 days at 5% CO2 in a 37°C incubator ...
-
bioRxiv - Immunology 2021Quote: ... 10 U/mL IL-2 from R&D Systems (1150-ML), 5 U/mL IL-12 p70 from PeproTech (210-12) ...
-
bioRxiv - Neuroscience 2019Quote: ... and glial derived neurotrophic factor (2 ng/ml; R&D Systems). One day after the initiation of differentiation ...
-
bioRxiv - Immunology 2019Quote: ... with addition of rhIL-2 (R&D Systems, 300 IU/ml). After 3 days ...
-
bioRxiv - Bioengineering 2021Quote: ... binding to basic fibroblast growth factor (FGF-2, R&D systems) and Vascular Endothelial Growth Factor 165 (VEGF165 ...
-
bioRxiv - Microbiology 2020Quote: ... and 2 ng/ml recombinant mouse TGF-β (R&D Systems). Cells were incubated with bacterial lysates at 37°C for 72 hours ...
-
bioRxiv - Neuroscience 2022Quote: ... goat anti-Lipocalin-2 (Lcn2) (1:200, R&D systems, AF1857), goat anti-Clusterin (Clu ...
-
bioRxiv - Immunology 2022Quote: ... and Human ULBP-2 DuoSet ELISA (R&D Systems, Cat. DY1298) kits according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2022Quote: ... and recombinant human IFNγ (2 IU/mL, R&D Systems, 285IF) for 16-20 hours ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 2 ng/μL rhIFNγ (R&D Systems, 285-IF-100). Cell were incubated at 37 C 5% CO2 and 24 hours later ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 2% fetal bovine serum (R&D systems, Cat# S11150) and 20U/mL Penicillin-Streptomycin (Gibco ...
-
bioRxiv - Neuroscience 2022Quote: ... Basic fibroblast growth factor (FGF-2, 20ng/ml, R&D systems) and epidermal growth factor EGF (10ng/ml ...